Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 18.79
-1.13 (-5.67%)
Sep 11, 2026, 3:59 PM HKT
Medtide Revenue
Medtide had revenue of 234.52M CNY in the half year ending June 30, 2026, with 18.77% growth. This brings the company's revenue in the last twelve months to 550.84M, up 10.49% year-over-year. In the year 2025, Medtide had annual revenue of 570.09M with 28.91% growth.
Revenue (ttm)
550.84M CNY
Revenue Growth
+10.49%
P/S Ratio
4.44
Revenue / Employee
924.22K CNY
Employees
596
Market Cap
2.82B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 570.09M | 127.86M | 28.91% |
| Dec 31, 2024 | 442.23M | 105.45M | 31.31% |
| Dec 31, 2023 | 336.77M | -14.07M | -4.01% |
| Dec 31, 2022 | 350.84M | 68.71M | 24.35% |
| Dec 31, 2021 | 282.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 2.20B |
| Frontage Holdings | 2.18B |
| Antengene Corporation | 652.54M |
| BioDlink International Company | 582.45M |
| Laekna | 296.69M |
| Mirxes Holding Company | 166.32M |
| HJ Science | 16.30M |
| Jiangsu Recbio Technology | 568.00K |